INBIOSIS Research Hub

Expertise map › Medicine › Physiology

Alzheimer's disease research and treatments

8 journal papers · 146 citations · 3 researchers at INBIOSIS

Who works on this

ranked by depth of expertise — output, citations and focus

Most cited work in this topic

  1. Tocotrienol-Rich Fraction Modulates Amyloid Pathology and Improves Cognitive Function in AβPP/PS1 Mice
    2016 · Journal of Alzheimer s Disease · 49 citations bronze OA
    doi.org/10.3233/jad-160685
  2. Synthetic Curcumin Analogs as Inhibitors of β -Amyloid Peptide Aggregation: Potential Therapeutic and Diagnostic Agents for Alzheimer's Disease
    2015 · Mini-Reviews in Medicinal Chemistry · 39 citations
    doi.org/10.2174/138955751513150923101841
  3. Modulation of Proteome Profile in AβPP/PS1 Mice Hippocampus, Medial Prefrontal Cortex, and Striatum by Palm Oil Derived Tocotrienol-Rich Fraction
    2019 · Journal of Alzheimer's Disease · 17 citations hybrid OA
    doi.org/10.3233/JAD-181171
  4. Study of tau pathology in male rTg4510 mice fed with a curcumin derivative Shiga-Y5
    2018 · PLoS ONE · 13 citations gold OA
    doi.org/10.1371/journal.pone.0208440
  5. The effect of α-tocopherol, α- and γ-tocotrienols on amyloid-β aggregation and disaggregation in vitro
    2021 · Biochemistry and Biophysics Reports · 12 citations gold OA
    doi.org/10.1016/j.bbrep.2021.101131
  6. Effect of Age on the Protein Profile of Healthy Malay Adults and its Association with Cognitive Function Competency
    2018 · Journal of Alzheimer s Disease · 8 citations bronze OA
    doi.org/10.3233/jad-180511
  7. Differential accumulation of tau pathology between reciprocal F1 hybrids of rTg4510 mice
    2021 · Scientific Reports · 8 citations gold OA
    doi.org/10.1038/s41598-021-89142-2
  8. P2‐046: CURCUMIN DERIVATIVE WITH C‐4 SUBSTITUENT ATTENUATED AMYLOID DEPOSITION, BUT DID NOT AFFECT TAU PATHOLOGY IN MOUSE MODELS
    2018 · Alzheimer s & Dementia · 0 citations bronze OA
    doi.org/10.1016/j.jalz.2018.06.730